Publications by authors named "T Monney"

Claim this Profile
B
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidity.
Jeremy Loyau, Thierry Monney, Marco Montefiori, Fedir Bokhovchuk, Jeremy Streuli

MAbs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.
Laura Carretero-Iglesia, Olivia J Hall, Jérémy Berret, Daniela Pais, Carole Estoppey, Thierry Monney

Nat Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.
C Grandclément, C Estoppey, E Dheilly, M Panagopoulou, T Monney

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma.
Blandine Pouleau, Carole Estoppey, Perrine Suere, Emilie Nallet, Amélie Laurendon, Thierry Monney

Blood· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development.
Romain Ollier, Paul Wassmann, Thierry Monney, Christelle Ries Fecourt, Sunitha Gn

MAbs· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis